(Q40983434)

25 September 2017

Inactivation of kallikrein in human plasma (English)

1 reference

25 September 2017

F. van der Graaf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6184384

23 August 2023

J. A. Koedam

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6184384

23 August 2023

B. N. Bouma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6184384

23 August 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

PMCID

436847

full work available at URL

25 September 2017

https://europepmc.org/articles/PMC436847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6184384

https://europepmc.org/articles/PMC436847?pdf=render

23 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6184384

http://www.jci.org/articles/view/110743/files/pdf

23 August 2023

1 reference

https://api.crossref.org/works/10.1172/JCI110743

Journal of Clinical Investigation

23 August 2023

published in

1 reference

25 September 2017

71

1 reference

25 September 2017

149-158

1 reference

25 September 2017

1

1 reference

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Inhibitors of kallikrein in human plasma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Inhibitory spectrum of alpha 2-plasmin inhibitor

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Studies on plasma inhibitors of plasma kallikrfin using chromogenic peptide substrate assays

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Interaction of plasma kallikrein with the C1 inhibitor

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Prekallikrein deficiency in man

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=436847

Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein

17 June 2018

1 reference

12 December 2020

Inhibition of purified plasma Kallikrein by antithrombin III and heparin

1 reference

12 December 2020

Inactivation and binding of human plasma kallikrein by antithrombin III and heparin

1 reference

12 December 2020

Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate

1 reference

12 December 2020

Activation of the early components of the classical complement pathway under physiologic conditions

1 reference

12 December 2020

The contact activation mechanism in human plasma: activation induced by dextran sulfate

1 reference

12 December 2020

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

1 reference

12 December 2020

Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation

1 reference

12 December 2020

Activation of plasminogen by human plasma kallikrein

1 reference

12 December 2020

Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator

1 reference

12 December 2020

[ -Antitrypsin and c 1-inactivator: progressive inhibitors of human and porcine kallikrein]

1 reference

12 December 2020

The inhibition of human plasma Kallikrein by antithrombin III

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI110743

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

PMCID

436847